Skip to main content
Journal of Lipid Research logoLink to Journal of Lipid Research
. 2024 Jul 17;65(8):100597. doi: 10.1016/j.jlr.2024.100597

Highly flexible cell membranes are the key to efficient production of lipophilic compounds

Qiyao Zhu 1,2,, Sijia Wang 1,2,, Gang Fu 2,3,4,∗,, Fengming Guo 2, Wei Huang 2, Tengyue Zhang 2, Huina Dong 2,3,4, Zhaoxia Jin 1,, Dawei Zhang 2,3,4,
PMCID: PMC11367113  PMID: 39029799

Abstract

Lipophilic compounds have a variety of positive effects on human physiological functions and exhibit good effects in the prevention and treatment of clinical diseases. This has led to significant interest in the technical applications of synthetic biology for the production of lipophilic compounds. However, the strict selective permeability of the cell membrane and the hydrophobic nature of lipophilic compounds pose significant challenges to their production. During fermentation, lipophilic compounds tend to accumulate within cell membrane compartments rather than being secreted extracellularly. The toxic effects of excessive lipophilic compound accumulation can threaten cell viability, while the limited space within the cell membrane restricts further increases in production yield. Consequently, to achieve efficient production of lipophilic compounds, research is increasingly focused on constructing robust and multifunctional microbial cell factories. Utilizing membrane engineering techniques to construct highly flexible cell membranes is considered an effective strategy to break through the upper limit of lipophilic compound production. Currently, there are two main approaches to cell membrane modification: constructing artificial storage compartments for lipophilic compounds and engineering the cell membrane structure to facilitate product outflow. This review summarizes recent cell membrane engineering strategies applied in microbial cell factories for the production of liposoluble compounds, discussing the challenges and future prospects. These strategies enhance membrane flexibility and effectively promote the production of liposoluble compounds.

Supplementary key words: cell membrane engineering, lipophilic compounds, synthetic biology, microbial cell factories, artificial storage compartments, product outflow


As the world faces the depletion of fossil fuel resources and increasing environmental degradation, there is new urgency to discover sustainable and eco-friendly methods for chemical production. Engineered microbial cell factories, with their potential to convert low-value renewable resources into high-value compounds, stand at the forefront as a promising alternative for chemical production (1). Lipophilic compounds are a class of substances carrying hydrophobic groups such as hydrocarbon and ester groups. Naturally lipophilic compounds produced through microbial fermentation are widely used in the fields of medicine, food, chemical engineering, and cosmetics. Among them, lipophilic compounds such as carotenoids, menaquinone-7, and lycopene are of particular interest due to their unique physiological functions in the human body (Fig. 1A) (2, 3, 4, 5).

Fig. 1.

Fig. 1

The application of membrane engineering technology in the production of lipophilic compounds. A: attractive lipophilic compounds. B: the DBTL (Design-Build-Test-Learn) cycle centered on metabolism serves as the core idea for the construction of microbial cell factories. C: cell membrane structure, lipophilic compounds (represented by red triangles) can be excreted from the cytoplasm by transporter proteins, but most accumulate in the phospholipid bilayer.

The hydrophobic groups of lipophilic compounds form hydrophobic interactions with the water environment, making it difficult to dissolve into water (6). Therefore, the production of lipophilic compounds using microbial fermentation may be challenging. The inherent inability of lipophilic compounds to traverse the cell membrane results in their aggregation in the cytoplasm as lipid clusters or accumulation within membrane compartments, which spatially restricts the production rate of lipophilic compounds. Despite attempts at enhancing metabolic pathways, this spatial limitation hinders the effective increase in yield (7).

Cellular membranes, a universal feature across a wide range of biological entities, function as the essential bridge between the internal cellular environment and the external world (8). They play an indispensable role in preserving normal cellular functions and structural integrity. As one of the most complex cellular organelles, the cell membrane's intact structure is essential for its functions. However, the membrane's fluidity grants it a high degree of structural plasticity, allowing changes in its composition and structure within a controlled range without causing membrane damage or cell death (9, 10). Utilizing membrane engineering techniques to modify the components and structure of the cell membrane can enhance its flexibility, offering a promising strategy to overcome the challenge of difficulty in exporting lipophilic compounds produced by microorganisms. In the field of synthetic biology, numerous studies have demonstrated the significant potential of membrane engineering in constructing robust and multifunctional microbial cell factories. These advancements include engineering membrane components to create artificial storage compartments for lipophilic compounds, incorporating surfactants to modify membrane permeability, engineering membrane transport proteins to facilitate product efflux, and forming membrane vesicles to enhance product export.

In this review, we begin by presenting the structural features of membranes and summarizing the significant research advancements in this domain. Subsequently, we provide a detailed discussion of the diverse physiological health benefits of lipophilic compounds, exemplified by carotenoids and menaquinone-7, and highlight the challenges faced by microbial cell factories in producing these compounds. Finally, by reviewing recent applications of cell membrane engineering techniques in biosynthesis, we emphasize that highly flexible cell membranes are the key to overcoming the limitations in the production of lipophilic compounds.

The Structure of the Cell Membrane

Lipid molecules and proteins are interconnected through non-covalent interactions to form the cell membrane (11). Phospholipid molecules, which act as the foundational units of the cell membrane's architecture, account for the majority of membrane lipids. Each phospholipid molecule consists of a hydrophilic head group and two hydrophobic fatty acid tails. Through hydrophobic interactions and van der Waals forces, phospholipid molecules spontaneously organize into a compact phospholipid bilayer structure. This arrangement positions the hydrophobic tails inward and the hydrophilic heads outward, effectively segregating the cell’s internal environment from the external milieu (12). As shown in Fig. 1C, proteins interact with the phospholipid bilayer in various ways. Most membrane proteins, referred to as transmembrane proteins, are embedded in the phospholipid bilayer and perform diverse functions of the cell membrane, including the transport of specific molecules and the catalysis of membrane-associated reactions. In addition, the outer layer of the cell membrane also contains sugars covalently bound to lipids, forming glycoproteins. These glycoproteins, existing as polysaccharide chains of complete membrane protein polysaccharides, primarily reside outside the cell as part of the extracellular matrix. Glycoproteins play a crucial role in intercellular signal transmission, helping to maintain intercellular distances and prevent unnecessary protein interactions (13).

In the quest to understand the structure and function of the cell membrane, researchers have proposed various models to elucidate the relationship between the two. In 1972, S. J. Singer and Garth L. Nicolson introduced the fluid mosaic model, which characterizes the cell membrane structure as a fluid phospholipid bilayer that forms the fundamental framework of the membrane. Proteins can be embedded in, envelop, or penetrate the phospholipid bilayer (11). These proteins and phospholipids exhibit a degree of fluidity, rendering the membrane structure in a state of constant flux. Consequently, the structure of the cell membrane is mechanically fluid and functionally selectively permeable. Although the fluid mosaic model remains the leading theory for explaining the characteristics of the cell membrane, it is essential to acknowledge that the complex structure and dynamic properties of the membrane cannot be fully explained by a single model. Continual progress in nanotechnology and imaging technology, together with the use of advanced experimental tools and research methods like Atomic Force Microscopy (AFM) and Single Molecule Force Spectroscopy (SMFS), have enabled an in-depth exploration of various cell membrane structures (14), leading to revisions and supplements to the fluid mosaic model (8, 15, 16, 17). As more complex structures with the cell membrane are gradually revealed, the fluid mosaic model appears insufficient in providing theoretical support for deeper levels of cell membrane structure. Therefore, the raft hypothesis has once again attracted the attention of researchers. Unlike the fluid mosaic model, the raft hypothesis proposes that specific lipids in the cell membrane form lateral compartments, termed lipid rafts (18). The experimental results from super-resolution microscopy reveal the existence of raft structures in living cells, opening up a new realm for the study of cell membrane structure and function (19, 20). Lipid rafts, rich in cholesterol, myelin proteins, and membrane proteins, perform various functions on the cell membrane, including signal transduction, protein-mediated endocytosis, and viral infection (21, 22, 23). According to recent studies, the bacterial cell membrane also has raft structures identified as membrane-functional microdomains that are similar to those found in eukaryotic cells (24). Flotillin-like proteins are situated in the membrane functional microdomains and play a crucial role in recruiting proteins and maintaining FMM structure (25, 26). Furthermore, researchers have recognized that specific interactions among membrane proteins and between lipid domains may restrict the lateral movement of the cell membrane (16, 27). Numerous experimental findings indicate that transmembrane proteins cannot move freely within the plane of the cell membrane, and the presence of lipid domains further slows diffusion within the plasma membrane (28, 29). This suggests that the fluid dynamics of the lipid bilayer may not support free planar diffusion as originally described in the initial version of the fluid mosaic model. The 2D-gel model proposed by Adam et al. offers fresh insights into cell membrane dynamics. Their research findings show that the purified phospholipid bilayer, undisturbed by external forces, can flow on the membrane plane akin to honey in vitro. In cells, however, the obstruction of transmembrane proteins imparts the membrane with the properties of a semi-solid gel (29). This finding is significant for understanding how membrane tension activates ion channels and regulates the dynamic structure of the cell membrane. Regrettably, the role and potential impact of raft structures in the 2D-gel model have not been addressed.

Challenges in the Production of Lipophilic Compounds

Lipophilic compounds, characterized by their hydrophobic groups, encompass a variety of chemical substances and typically tend to dissolve in lipids or nonpolar substances. Figure 1A presents the chemical structures of several lipophilic compounds that are of interest in the medical and health food sectors. Notably, natural lipophilic compounds such as carotenoids, menaquinone-7, and lycopene have garnered considerable attention due to their unique physiological benefits to human health. Carotenoids, exemplified by β-carotene, possess potent antioxidant properties, and their consumption has been associated with a reduced risk of cancer (30). Astaxanthin, another member of the carotenoid family, is commonly found within the flesh of a wide variety of fish species, as well as in the shells of crustaceans like shrimp and crabs (31). As shown in Fig. 2, Astaxanthin boasts an antioxidant activity that is tenfold greater than that of β-carotene, rendering it highly effective in the prevention and treatment of a variety of clinical conditions, including cancer, ocular diseases, atherosclerosis, and diabetes (32). Consequently, the development of microbial synthesis technology for astaxanthin is attracting increasing attention. Menaquinone-7 (MK-7) is a subtype of Vitamin K2, which has a higher bioavailability and a longer half-life in the human body (33). MK-7, gaining popularity as a dietary supplement, is highly valued for its efficacy in the prevention of osteoporosis and the promotion of blood coagulation (34). Recent studies have revealed that patients with COVID-19 exhibit significantly lower levels of MK-7 compared to healthy control subjects. Furthermore, it has been suggested that a deficiency of MK-7 within the human body may contribute to the exacerbation of COVID-19 symptoms (35, 36). Lycopene, recognized as a natural and edible pigment, is renowned for its robust antioxidant capabilities. Upon consumption, it can exert a beneficial influence at various stages of atherosclerosis progression (37).

Fig. 2.

Fig. 2

The physiological impacts of astaxanthin and menaquinone-7 on human health.

Amid escalating concerns over various chronic diseases in recent years, there has been a surge in market demand for lipophilic compounds, which have demonstrated efficacy in the prevention and treatment of most chronic diseases. Consequently, the production of environmentally friendly and safe lipophilic compounds using microbial cell factories holds great promise. The design-build-test-learn (DBTL) cycle of synthetic biology methods has emerged as the primary strategy for constructing microbial cell factories (Fig. 1B) (38), significantly advancing the industrial production of lipophilic compounds. However, the spatial constraints of the cell membrane pose a challenge to the efficient production of these compounds. In the course of producing lipophilic compounds via microbial cell factories, these compounds exhibit a propensity to accumulate within the lipid-rich cell membrane, as opposed to being expelled from the cell. This suggests that the limited capacity of the cell membrane inherently dictates the maximum yield of lipophilic compounds, a perspective corroborated by pertinent literature (39). At the same time, it has been found that the accumulation of various lipophilic compounds in the compartments of the cell membrane can induce cytotoxicity and interfere with the normal function of the membrane (40, 41, 42). To solve this problem, current research focuses on using cell membrane engineering technology to adjust the components and structure of the microbial cell membrane to make the cell membrane more flexible, thereby providing more storage space for lipophilic compounds or helping them flow out from the cell membrane.

Membrane Morphology Engineering Constructs Artificial Storage Compartments

The hydrophobic nature of lipophilic compounds, along with precise regulation by cell membranes for substance entry and exit, determines that these compounds cannot be easily expelled from the cell membrane. Instead, they accumulate on lipid-rich cell membranes or form hydrophobic lipid clusters within the cytoplasm. Regardless of the mode of aggregation, the substantial accumulation of lipophilic compounds disrupts normal cellular functions in microbial cell factories (43). Therefore, constructing artificial storage depots to overcome the capacity limitations imposed by cell membrane space for lipophilic compounds holds significant importance. A promising strategy involves enhancing the hydrophobic environment within cells to encapsulate lipophilic products. Both lipid engineering, which creates lipid droplets by enhancing endogenous lipid biosynthesis pathways within cells, and membrane engineering, which modifies the morphological characteristics of the cell membrane by regulating the expression of membrane morphology-related genes, have been extensively utilized in the field of biotechnology (7). The application methods of lipid engineering are beyond the scope of this review, and numerous excellent publications have summarized it (44, 45, 46). Here we discuss the potential of cell membrane morphological changes as a hydrophobic product storage warehouse and introduce the application cases of membrane engineering technology in the production of lipophilic compounds.

Lipids are the primary hydrophobic components of the cell membrane (47). Increasing the quantity of hydrophobic components in the cell membrane is beneficial for the accumulation of lipophilic compounds. The biosynthesis of Diacylglycerol-3-P is enhanced by the over-expression of PlsB and PlsC, which provides an abundant precursor supply for the biosynthesis pathway of membrane components. This leads to an increase in the total amount of E. coli cell membrane components along with the enhanced production of β-carotene (48). Cell membrane curvature implies that cells have a larger surface area-to-volume ratio, providing increased storage space for the production of lipophilic compounds (49). Wu et al. heterologously expressed multiple genes that regulate cell membrane curvature in Escherichia coli, aiming to construct an artificial storage compartment for lipophilic compounds. These genes include the mannitol permease MtlA, the chemotactic receptor Tsr, and the membrane curvature protein Almgs. The curved membrane structure folds into a wrinkled shape, and the increased hydrophobic components provide more space for the storage of β-carotene, with the overexpression of the Almgs membrane curvature protein having the most significant effect on the increase in β-carotene production (50). As shown in Fig. 3, Wu et al. increased the production of lycopene by 12% by heterologously expressing the membrane curvature protein Almgs from Acholeplasma laidlawii. By overexpressing the genes involved in the E.coli cell membrane synthetic pathway, namely plsB, plsC, and dgkA, the total membrane content was increased. This expansion of the lipophilic compound storage space led to a further enhancement in lycopene production. Compared to the parental strain, the engineered strain with modified membrane morphology exhibited a 1.32-fold increase in lycopene yield (51). Cell membrane morphology engineering through heterologous expression of membrane curvature proteins has been demonstrated as an effective strategy to enhance the production of lipophilic compounds. However, the partial loss of membrane function and the potential impact on cellular activities caused by changes in cell membrane morphology and components cannot be ignored.

Fig. 3.

Fig. 3

Cell membrane morphology engineering. The membrane-curving protein Almgs, derived from Acholeplasma laidlawii, is heterologously expressed in E. coli, causing the membrane morphology to become curved. PlsB, glycerol-3-phosphate-acyltransferase; PlsC, 1-acylglycerol-3-phosphate-acyltransferase (51).

Improving Cell Membrane Permeability to Alleviate Cytotoxicity

Bacteria have evolved a precise material transport system to tightly regulate the uptake of nutrients and the efflux of metabolic products. This relies on the phospholipid bilayer of the cell membrane and the embedded transport proteins within it (11). The phospholipid bilayer of the cell membrane separates the external environment from the cell’s interior. It allows small molecules like H2O and CO2 to pass freely, while larger compounds rely on transport proteins for transportation. During production, the cell membrane’s stringent selectivity hinders the efflux of lipophilic compounds, and allowing an excessive accumulation of these compounds can threaten the survival of host cells. Researchers are exploring various strategies to construct highly flexible cell membranes, aiming to continuously enhance lipophilic compound production and mitigate cellular toxicity.

Recent research has found that the permeability of the cell membrane changes after treatment with surfactants (52). Surfactant molecules, possessing amphiphilicity akin to phospholipid molecules, distribute into the membrane due to intermolecular forces. When a sufficient number of surfactant monomers aggregate in the cell membrane to form micelles, they dissolve phospholipid molecules, thereby increasing cell membrane permeability (53). Table 1 summarizes recent applications of surfactants to enhance cell membrane permeability. Surfactants such as Sodium Dodecyl Sulfate (SDS) and Triton X-100 can be used to dissolve the amphiphilic phospholipids on the cell membrane, facilitating the expulsion of metabolic products through the pores formed on the cell membrane (54). While enhancing cell membrane permeability, Tween-80 and Triton X-100 do not significantly affect cell morphology and function. Therefore, they are preferred surfactants for optimizing microbial fermentation. Cai et al. significantly enhanced the yield of hypocrellin to 780.6 mg/L in the fermentation process of Shiraia sp. SUPER-H168 by adding 0.6% Triton X-100. Simultaneously, it also reduces the fermentation duration (55). Another benefit of using surfactants during the biosynthesis of lipophilic compounds is to alleviate the accumulation of product in the cell membrane which could otherwise result in cytotoxicity. For example, lycopene is a lipophilic natural pigment, and the hydrophobic phospholipid molecular layer provides a storage space for this lipophilic compound. However, the limited cell membrane space and tolerance hinder further enhancement of lycopene production (5). Yoon et al. added 0.5% Tween-80 to the culture medium, which reduced the phenomenon of cell aggregation caused by the accumulation of lycopene in the cell membrane, while simultaneously promoting cell growth and the yield of lycopene (56). Bacillus subtilis serves as the primary chassis cell for the production of MK-7. However, the accumulation of MK-7 in the cell membrane leads to superoxide cytotoxicity, which impedes normal cellular activities (40, 57). To facilitate the release of MK-7 from the cell membrane into the fermentation broth, Zhou et al. attempted to add various types of surfactants to the culture medium, including cationic surfactant CTAB, anionic surfactant Sodium Dodecyl Sulfate, non-ionic surfactant Tween-80, Polyethylene Glycol-200, and amphoteric surfactants such as Diammonium Citrate and Betaine. The results demonstrated that the addition of 0.7% Tween-80 significantly increased the yield of extracellular MK-7, boosting the total yield of MK-7 by 80.3%. Scanning electron microscopy and flow cytometry results confirmed that the mixed micelles formed by the dissolution of phospholipid molecules and surfactant molecules altered the cell membrane structure, thereby facilitating the excretion of MK-7 outside the cell (58). Furthermore, Yi et al. added the non-ionic surfactant Brij-58 to the culture medium of Bacillus subtilis natto, which increased the total yield and secretion rate of MK-7 by 48.0% and 56.2% respectively. Brij-58 molecules adhere to the cell surface through van der Waals forces, hydrogen bonding, and hydrophobic effects, reducing the surface tension between the cell surface and the fermentation broth, increasing the fluidity of the cell membrane while reducing the integrity of the cell membrane structure, thereby leading to an increase in cell membrane permeability. This strategy provides a new research direction for the optimization of the MK-7 fermentation process (59). While adding surfactants to the fermentation broth may increase the workload for product purification, judicious use of surfactants can enhance the efficient production of lipophilic compounds. As a key component of chemical cleaning agents, surfactants are cost-effective and readily available, making them promising candidates for large-scale application in the industrial production of lipophilic compounds.

Table 1.

The application of surfactants in the fermentation process of microbial cell factories

Surfactants Chassis cell Product Production References
Triton X-100 Shiraia sp. SUPER-H168 hypocrellin Optimal supplementation at the onset of fermentation results in a yield of 780.6 mg/L; (36)
Tween 80 Escherichia coli Lycopene Upon the incorporation of 0.5% Tween 80 into the culture medium, the yield escalated to 102 mg/L, concurrently facilitating the prevention of agglomeration; (37)
Tween 80 Bacillus subtilis Menaquinone-7 Upon the incorporation of 0.7% Tween-80, the intracellular and extracellular productivities escalated to 28.8 mg/L and 59.2 mg/L respectively; (40)
Brij-58 Bacillus natto Menaquinone-7 The overall productivity and secretion rate witnessed respective enhancements of 48% and 56.2%; (41)
Tween 80 Aspergillus nidulans Echinocandin B Supplementation of Tween 80 in the culture medium enhances the yield to 2,584 mg/L; (42)
Sodium Dodecyl Sulfate Corynebacterium glutamicum L-isoleucine The yield escalated to 43.67 g/L, marking a 13.01% enhancement relative to the control, concurrently effectuating a significant reduction in by-product formation; (43)
Triton X-100 E. coli BL21 Truncated recombinant mannanases Incorporation of 0.1% Triton X-100 culminated in a total yield of 9,284.64 U/ml, with an extracellular productivity reaching 74%; (44)
Tween 80 and Sodium Lauryl Sulfate Bacillus subtilis BI19 Amylase The supplementation of Tween 80 and sodium lauryl sulfate led to respective enhancements in enzyme yield by 28% and 15%; (45)
Polyoxyethyleneoleyl Flavobacterium sp. M1-14 Vitamin K2 The yield escalated to 25.55 mg/L, marking a 252.4% enhancement relative to the control; (46)
Tween 80 Bacillus subtilis Levan Upon the incorporation of 0.5 g/L Tween 80, the yield peaked at 48.8 g/L. (47)

Membrane Transport Protein Engineering

Membrane transport proteins regulate the transport process of substances through facilitated diffusion. Most membrane transport proteins possess specific receptors, allowing only particular compounds to freely traverse the cell membrane (60). For systematic research, biological data from 15,228 distinct membrane transport systems across various organisms are cataloged in the Transporter Classification Database (TCDB, https://www.tcdb.org/), which researchers can access free of charge. A rigorous classification system has been established based on the functional and structural characteristics of transport proteins (61, 62, 63). The emergence of The Transporter Classification Database has opened up vast opportunities for membrane transport system innovation within the synthetic biology community.

Fatty acids are essential for the cytoplasmic membrane and are used extensively in the chemical and fuel sectors. When they build up in E. coli, however, they can induce stress responses and cell lysis (64). According to experimental findings, fatty acids are excreted from cells through a transcellular enveloping transport mechanism, with the AcrAB-TolC efflux pump performing the majority of this role (65). Wu et al. further demonstrated the importance of the AcrAB-TolC efflux pump for fatty acid production. By overexpressing the resistance-nodulation-cell division (RND) family transporter acrE, mdtE, and mdtC, the yield of medium-chain fatty acids increased by 46.4%, 65.2%, and 33.8% respectively. After overexpressing acrE, mdtE, and mdtC in combination and knocking out the multidrug efflux pumps cmr, the yield of medium-chain fatty acids increased more than twice (66). Heterologous expression of transporter proteins has also been proven to be an effective strategy to promote product efflux. Chen et al. expressed the heterologous ABC transport protein of Yarrowia lipolytica into Saccharomyces cerevisiae, which significantly increased the tolerance to undecane and tridecane (67). In addition, for compounds with clear membrane transport mechanisms, the application of membrane transport protein engineering can be more flexible. For instance, knocking out the heme precursor transporter genes cysG, hemX, and cyoE reduces the loss of heme precursors, which helps to boost the flux of heme biosynthesis. Overexpressing the heme extracellular transport genes dpp and ccm effectively increases the yield of heme (68). In another study, overexpression of the ABC transport protein permease YcjP, identified through transcriptomics, significantly enhanced E. coli’s ability to produce caffeic acid (69). Membrane transport protein engineering offers an effective solution to address the accumulation of lipophilic compounds. However, the complex process of identifying and elucidating membrane transport mechanisms limits research progress. As a result, the application scope of membrane transport protein engineering in constructing microbial cell factories remains quite limited. The use of transcriptomics to mine potential transport proteins can effectively improve the efficiency of membrane transport protein engineering.

Engineering Membrane Vesicles Facilitates Product Efflux

Bacterial membrane vesicles were first discovered in E. coli (70). The controlled bubbling of the outer membrane of Gram-negative bacteria or cell lysis mediated by endolysins leads to the formation of membrane vesicles (71). These vesicles participate in various cellular functions, including cell communication, component modification, toxin transport, and DNA transfer (71, 72). The specific composition of the contents of membrane vesicles cannot be determined, but all types of membrane vesicles that have been discovered contain lipids, membrane proteins, lipoproteins, and a few soluble proteins attached to the periphery (72). Due to their unique transport and occurrence mechanisms, the application of membrane vesicles in the field of biotechnology is becoming increasingly widespread (73). For lipophilic compounds, membrane vesicles serve as natural transport carriers. When cellular membranes are perturbed to form vesicles, lipophilic compounds that remain encapsulated on the cell membrane are transported outside the cell along with the vesicles. Wu et al. disrupted the integrity of the outer membrane of E. coli by knocking out the outer membrane lipoprotein gene, which made membrane vesicles more likely to occur. The β-carotene accumulated on the membrane was transported to the culture medium with the membrane vesicles. At the same time, to prevent excessive loss of cell membrane components, the synthesis pathway of cell membrane components was enhanced, leading to a 24-fold increase in the extracellular production of β-carotene (48). As shown in Fig. 4, Eric Fordjour et al. disrupted the integrity of the outer membrane by knocking out murein lipoprotein LPP, lipoprotein NlpI, inner membrane permease protein MlaE, and membrane-anchored protein in E. coli TolA-TolQ-TolR, making the cells more prone to vesicle formation. At the same time, it was found that the production of membrane vesicles significantly increased the unsaturated fatty acid content of E. coli, thereby increasing the permeability of the cell membrane. By adding 20% dodecane to the culture medium for in situ extraction, the intracellular and extracellular production of lycopene was significantly increased. In addition, different mutant strains of the membrane protein gene tolA produced membrane vesicles of different sizes, and strains with reduced cell size showed a higher release rate of membrane vesicles. However, it is regrettable that current data cannot summarize the correlation between the number of membrane vesicles and the secretion rate of lycopene. The increase in extracellular lycopene production is believed to be due to the increased permeability and fluidity of the membrane (74). On the other hand, Mara Reifenrath used the Zera domain to induce the formation of artificial vesicles, which have a different formation mechanism from traditional membrane vesicles. These are anchored to the endoplasmic reticulum of S. cerevisiae and do not fall off, serving as a target for enzyme compartmentalization in the synthesis pathway, which is conducive to the aggregation effect of enzymes (75).

Fig. 4.

Fig. 4

Membrane vesicles are utilized in the extrusion process of lycopene. A: In microbial cell factories, the lycopene biosynthesis pathway is assembled to enhance metabolic flux and promote lycopene production. B: By knocking out membrane-stabilizing proteins, the integrity of the outer membrane is disrupted, thereby inducing the production of membrane vesicles. C: Lycopene is excreted extracellularly along with the membrane vesicles. LPP, murein lipoprotein; MepS, murein DD-endopeptidase; MlaA/MlaC/MlaE, membrane lipid asymmetry pathway; NlpI, lipoprotein nlpI precursor; OmpC/OmpF/OmpA, outer membrane proteins; TolAB-Pal, Tol-Pal pathway (74).

Gram-positive bacteria have a dense cell wall structure, so researchers have long overlooked the possibility of the occurrence of membrane vesicle mechanisms in Gram-positive bacteria. Recent research shows that Gram-positive bacteria also exhibit phenomena of membrane vesicle formation caused by bacterial autolysis (76, 77, 78). Unlike the formation of membrane vesicles in Gram-negative bacteria, the autolysins of Gram-positive bacteria cannot completely dissolve the cell wall, leading to the formation of membrane vesicles after the cell membrane ruptures, which cannot be expelled outside the cell wall. This mechanism of membrane vesicle formation is referred to as bubbling cell death (72). This also implies that membrane vesicles have the potential to be applied in cell membrane engineering technology in Gram-positive bacteria.

Conclusion and Outlook

Recent advances in membrane engineering have positioned it as a potent strategy for creating multifunctional microbial cell factories specifically tailored for lipophilic compound production. This review highlights the crucial role of cell membranes in the production of lipophilic compounds. To mitigate the toxic effects of excessive lipophilic compound accumulation on the cell membrane, constructing highly flexible cell membranes through membrane engineering technology is essential for efficient production. However, as one of the most complex organelles in the cell, engineering membrane components and structures without interfering with the normal function of the cell membrane is challenging. The progress of membrane engineering technology is currently hindered by the lack of experimental evidence supporting theoretical models of the cell membrane (79).

With the continuous advancement of artificial intelligence technology in the field of biomedicine, computer-assisted scientific research will provide a more comprehensive blueprint for the construction process of highly flexible cell membranes. AlphaFold2, utilizing artificial intelligence technology, is poised to accelerate the research process of membrane proteins (80, 81). Moreover, the extensive use of machine learning platforms and generative artificial intelligence, combined with high-throughput instruments, can effectively reduce laboratory workload (82, 83). In the coming years, products powered by artificial intelligence will offer immense opportunities for the progression of membrane engineering technology. These products will contribute to the advancement of fundamental research in cell membranes and the development of synthetic biology technologies driven by machine learning platforms.

Data Availability

All data are contained within the manuscript. All reagents are available upon request from the authors.

Conflict of interest

The authors declare that they have no conflicts of interest with the contents of this article.

Acknowledgments

Author contributions

D. Z. and Z. J. conceptualization; Q. Z. and G. F. methodology; Q. Z. and G. F. writing–original draft; S. W., G. F., and D. Z. writing–review and editing; F. G., W. H., Q. Z. and H. D. resources; T. Z. formal analysis.

Funding and additional information

This work was supported by the National Key R&D Program of China (2022YFC2106100), the National Science Fund for Distinguished Young Scholars (22325807), the National Natural Science Foundation of China (22178372, 42177112), the Science Research Project of Liaoning Provincial Education Department (LJKMZ20220882), the Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project (TSBICIP-KJGG-011, TSBICIP-CXRC-055 and TSBICIP-CXRC-081).

Contributor Information

Gang Fu, Email: fu_g@tib.cas.cn.

Zhaoxia Jin, Email: jinzx2018@163.com.

Dawei Zhang, Email: zhang_dw@tib.cas.cn.

References

  • 1.Cho J.S., Kim G.B., Eun H., Moon C.W., Lee S.Y. Designing microbial cell factories for the production of chemicals. JACS Au. 2022;2:1781–1799. doi: 10.1021/jacsau.2c00344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wang C., Zhao S., Shao X., Park J.-B., Jeong S.-H., Park H.-J., et al. Challenges and tackles in metabolic engineering for microbial production of carotenoids. Microb. Cell Fact. 2019;18:55. doi: 10.1186/s12934-019-1105-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zhang C., Chen X., Too H.-P. Microbial astaxanthin biosynthesis: recent achievements, challenges, and commercialization outlook. Appl. Microbiol. Biotechnol. 2020;104:5725–5737. doi: 10.1007/s00253-020-10648-2. [DOI] [PubMed] [Google Scholar]
  • 4.Liao C., Ayansola H., Ma Y., Ito K., Guo Y., Zhang B. Advances in enhanced menaquinone-7 production from Bacillus subtilis. Front. Bioeng. Biotechnol. 2021;9 doi: 10.3389/fbioe.2021.695526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Li L., Liu Z., Jiang H., Mao X. Biotechnological production of lycopene by microorganisms. Appl. Microbiol. Biotechnol. 2020;104:10307–10324. doi: 10.1007/s00253-020-10967-4. [DOI] [PubMed] [Google Scholar]
  • 6.Angelova B., Schmauder H.-P. Lipophilic compounds in biotechnology—interactions with cells and technological problems12. J. Biotechnol. 1999;67:13–32. doi: 10.1016/s0168-1656(98)00139-4. [DOI] [PubMed] [Google Scholar]
  • 7.Palage A.M., Ward V.C. Strategies for production of hydrophobic compounds. Curr. Opin. Biotechnol. 2022;75:102681. doi: 10.1016/j.copbio.2022.102681. [DOI] [PubMed] [Google Scholar]
  • 8.Nicolson G.L. Update of the 1972 Singer-Nicolson fluid-mosaic model of membrane structure. Discoveries (Craiova) 2013;1:e3. doi: 10.15190/d.2013.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wang J., Ma W., Wang X. Insights into the structure of Escherichia coli outer membrane as the target for engineering microbial cell factories. Microb. Cell Fact. 2021;20:73. doi: 10.1186/s12934-021-01565-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wang J., Ma W., Fang Y., Zhang H., Liang H., Liu H., et al. Engineering the outer membrane could facilitate Better bacterial performance and effectively enhance Poly-3-Hydroxybutyrate accumulation. Appl. Environ. Microbiol. 2021;87 doi: 10.1128/AEM.01389-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Singer S.J., Nicolson G.L. The Fluid Mosaic Model of the Structure of Cell Membranes: cell membranes are viewed as two-dimensional solutions of oriented globular proteins and lipids. Science. 1972;175:720–731. doi: 10.1126/science.175.4023.720. [DOI] [PubMed] [Google Scholar]
  • 12.Sohlenkamp C., Geiger O. Bacterial membrane lipids: diversity in structures and pathways. FEMS Microbiol. Rev. 2016;40:133–159. doi: 10.1093/femsre/fuv008. [DOI] [PubMed] [Google Scholar]
  • 13.Wang H., Li G. Springer Singapore; Singapore: 2018. Membrane Biophysics. [Google Scholar]
  • 14.Shan Y., Wang H. The structure and function of cell membranes examined by atomic force microscopy and single-molecule force spectroscopy. Chem. Soc. Rev. 2015;44:3617–3638. doi: 10.1039/c4cs00508b. [DOI] [PubMed] [Google Scholar]
  • 15.Nicolson G.L. The Fluid-Mosaic Model of Membrane Structure: still relevant to understanding the structure, function and dynamics of biological membranes after more than 40 years. Biochim. Biophys. Acta. 2014;1838:1451–1466. doi: 10.1016/j.bbamem.2013.10.019. [DOI] [PubMed] [Google Scholar]
  • 16.Nicolson G.L., Ferreira de Mattos G. A brief introduction to some Aspects of the fluid-mosaic model of cell membrane structure and its importance in membrane lipid Replacement. Membranes (Basel) 2021;11:947. doi: 10.3390/membranes11120947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Nicolson G.L., Ferreira de Mattos G. The Fluid-Mosaic model of cell membranes: a brief introduction, historical features, some general principles, and its adaptation to current information. Biochim. Biophys. Acta Biomembr. 2023;1865:184135. doi: 10.1016/j.bbamem.2023.184135. [DOI] [PubMed] [Google Scholar]
  • 18.Mayor S., Rao M. Rafts: scale-dependent, active lipid organization at the cell surface. Traffic. 2010;5:231–240. doi: 10.1111/j.1600-0854.2004.00172.x. [DOI] [PubMed] [Google Scholar]
  • 19.Eggeling C., Ringemann C., Medda R., Schwarzmann G., Sandhoff K., Polyakova S., et al. Direct observation of the nanoscale dynamics of membrane lipids in a living cell. Nature. 2009;457:1159–1162. doi: 10.1038/nature07596. [DOI] [PubMed] [Google Scholar]
  • 20.Levental I., Levental K.R., Heberle F.A. Lipid rafts: controversies Resolved, Mysteries remain. Trends Cell Biol. 2020;30:341–353. doi: 10.1016/j.tcb.2020.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Simons K., Gerl M.J. Revitalizing membrane rafts: new tools and insights. Nat. Rev. Mol. Cell Biol. 2010;11:688–699. doi: 10.1038/nrm2977. [DOI] [PubMed] [Google Scholar]
  • 22.Rajendran L., Simons K. Lipid rafts and membrane dynamics. J. Cell Sci. 2005;118:1099–1102. doi: 10.1242/jcs.01681. [DOI] [PubMed] [Google Scholar]
  • 23.Rossman J.S., Lamb R.A. Influenza virus assembly and budding. Virology. 2011;411:229–236. doi: 10.1016/j.virol.2010.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.López D., Kolter R. Functional microdomains in bacterial membranes. Genes Dev. 2010;24:1893–1902. doi: 10.1101/gad.1945010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bramkamp M., Lopez D. Exploring the existence of lipid rafts in bacteria. Microbiol. Mol. Biol. Rev. 2015;79:81–100. doi: 10.1128/MMBR.00036-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lopez D. Molecular composition of functional microdomains in bacterial membranes. Chem. Phys. Lipids. 2015;192:3–11. doi: 10.1016/j.chemphyslip.2015.08.015. [DOI] [PubMed] [Google Scholar]
  • 27.Sanderson J.M. Resolving the kinetics of lipid, protein and peptide diffusion in membranes. Mol. Membr. Biol. 2012;29:118–143. doi: 10.3109/09687688.2012.678018. [DOI] [PubMed] [Google Scholar]
  • 28.Nicolson G.L., Ferreira de Mattos G. Fifty Years of the fluid-mosaic model of Biomembrane structure and organization and its importance in biomedicine with particular Emphasis on membrane lipid Replacement. Biomedicines. 2022;10:1711. doi: 10.3390/biomedicines10071711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Shi Z., Graber Z.T., Baumgart T., Stone H.A., Cohen A.E. Cell membranes resist flow. Cell. 2018;175:1769.e13. doi: 10.1016/j.cell.2018.09.054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Álvarez R., Vaz B., Gronemeyer H., Lera ÁR De. Functions, Therapeutic applications, and synthesis of Retinoids and carotenoids. Chem. Rev. 2014;114:1–125. doi: 10.1021/cr400126u. [DOI] [PubMed] [Google Scholar]
  • 31.Breithaupt D.E. Modern application of xanthophylls in animal feeding–a review. Trends Food Sci. Technol. 2007;18:501–506. [Google Scholar]
  • 32.Stachowiak B., Szulc P. Astaxanthin for the food Industry. Molecules. 2021;26:2666. doi: 10.3390/molecules26092666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Sato T., Inaba N., Yamashita T. MK-7 and its effects on Bone Quality and Strength. Nutrients. 2020;12:965. doi: 10.3390/nu12040965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Jadhav N., Ajgaonkar S., Saha P., Gurav P., Pandey A., Basudkar V., et al. Molecular pathways and roles for vitamin K2-7 as a health-beneficial Nutraceutical: challenges and opportunities. Front. Pharmacol. 2022;13:896920. doi: 10.3389/fphar.2022.896920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Mangge H., Prueller F., Dawczynski C., Curcic P., Sloup Z., Holter M., et al. Dramatic decrease of vitamin K2 subtype menaquinone-7 in COVID-19 patients. Antioxidants. 2022;11:1235. doi: 10.3390/antiox11071235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Berenjian A., Sarabadani Z. How menaquinone-7 deficiency influences mortality and morbidity among COVID-19 patients. Biocatal. Agric. Biotechnol. 2020;29:101792. doi: 10.1016/j.bcab.2020.101792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Khan U.M., Sevindik M., Zarrabi A., Nami M., Ozdemir B., Kaplan D.N., et al. Lycopene: food Sources, biological activities, and human health benefits. Oxid. Med. Cell Longev. 2021;2021:e2713511. doi: 10.1155/2021/2713511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Gurdo N., Volke D.C., Nikel P.I. Merging automation and fundamental discovery into the design–build–test–learn cycle of nontraditional microbes. Trends Biotechnol. 2022;40:1148–1159. doi: 10.1016/j.tibtech.2022.03.004. [DOI] [PubMed] [Google Scholar]
  • 39.Li C., Swofford C.A., Sinskey A.J. Modular engineering for microbial production of carotenoids. Metab. Eng. Commun. 2020;10 doi: 10.1016/j.mec.2019.e00118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Anand A., Chen K., Yang L., Sastry A.V., Olson C.A., Poudel S., et al. Adaptive evolution reveals a tradeoff between growth rate and oxidative stress during naphthoquinone-based aerobic respiration. Proc. Natl. Acad. Sci. U. S. A. 2019;116:25287–25292. doi: 10.1073/pnas.1909987116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Sung W.S., Lee I.-S., Lee D.G. Damage to the cytoplasmic membrane and cell death caused by lycopene in Candida albicans. J. Microbiol. Biotechnol. 2007;17:1797–1804. [PubMed] [Google Scholar]
  • 42.Chen L., Xiao W., Yao M., Wang Y., Yuan Y. Compartmentalization engineering of yeasts to overcome precursor limitations and cytotoxicity in terpenoid production. Front. Bioeng. Biotechnol. 2023;11 doi: 10.3389/fbioe.2023.1132244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ma T., Shi B., Ye Z., Li X., Liu M., Chen Y., et al. Lipid engineering combined with systematic metabolic engineering of Saccharomyces cerevisiae for high-yield production of lycopene. Metab. Eng. 2019;52:134–142. doi: 10.1016/j.ymben.2018.11.009. [DOI] [PubMed] [Google Scholar]
  • 44.Kikukawa H., Watanabe K., Kishino S., Takeuchi M., Ando A., Izumi Y., et al. Recent trends in the field of lipid engineering. J. Biosci. Bioeng. 2022;133:405–413. doi: 10.1016/j.jbiosc.2022.02.001. [DOI] [PubMed] [Google Scholar]
  • 45.Zhao Y., Zhang Y., Nielsen J., Liu Z. Production of β-carotene in Saccharomyces cerevisiae through altering yeast lipid metabolism. Biotech. Bioeng. 2021;118:2043–2052. doi: 10.1002/bit.27717. [DOI] [PubMed] [Google Scholar]
  • 46.Lin J.-L., Zhu J., Wheeldon I. Synthetic protein Scaffolds for Biosynthetic pathway Colocalization on lipid droplet membranes. ACS Synth. Biol. 2017;6:1534–1544. doi: 10.1021/acssynbio.7b00041. [DOI] [PubMed] [Google Scholar]
  • 47.Dufrisne M.B., Petrou V.I., Clarke O.B., Mancia F. Structural basis for catalysis at the membrane-water interface. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2017;1862:1368–1385. doi: 10.1016/j.bbalip.2016.11.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Wu T., Li S., Ye L., Zhao D., Fan F., Li Q., et al. Engineering an artificial membrane vesicle Trafficking system (AMVTS) for the excretion of β-carotene in Escherichia coli. ACS Synth. Biol. 2019;8:1037–1046. doi: 10.1021/acssynbio.8b00472. [DOI] [PubMed] [Google Scholar]
  • 49.Huo K., Zhao F., Zhang F., Liu R., Yang C. Morphology engineering: a new strategy to construct microbial cell factories. World J. Microbiol. Biotechnol. 2020;36:127. doi: 10.1007/s11274-020-02903-5. [DOI] [PubMed] [Google Scholar]
  • 50.Wu T., Ye L., Zhao D., Li S., Li Q., Zhang B., et al. Membrane engineering - a novel strategy to enhance the production and accumulation of β-carotene in Escherichia Coli. Metab. Eng. 2017;43:85–91. doi: 10.1016/j.ymben.2017.07.001. [DOI] [PubMed] [Google Scholar]
  • 51.Wu T., Ye L., Zhao D., Li S., Li Q., Zhang B., et al. Engineering membrane morphology and manipulating synthesis for increased lycopene accumulation in Escherichia coli cell factories. 3 Biotech. 2018;8:269. doi: 10.1007/s13205-018-1298-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Jamur M.C., Oliver C. Permeabilization of cell membranes. Methods Mol. Biol. 2010;588:63–66. doi: 10.1007/978-1-59745-324-0_9. [DOI] [PubMed] [Google Scholar]
  • 53.Xia W.J., Onyuksel H. Mechanistic studies on surfactant-induced membrane permeability enhancement. Pharm. Res. 2000;17:612–618. doi: 10.1023/a:1007581202873. [DOI] [PubMed] [Google Scholar]
  • 54.Lai M., Li X., Li J., Hu Y., Czajkowsky D.M., Shao Z. Improved clearing of lipid droplet-rich tissues for three-dimensional structural elucidation. Acta Biochim. Biophys. Sin (Shanghai) 2017;49:465–467. doi: 10.1093/abbs/gmx018. [DOI] [PubMed] [Google Scholar]
  • 55.Cai Y., Liao X., Liang X., Ding Y., Sun J., Zhang D. Induction of hypocrellin production by Triton X-100 under submerged fermentation with Shiraia sp. SUPER-H168. N. Biotechnol. 2011;28:588–592. doi: 10.1016/j.nbt.2011.02.001. [DOI] [PubMed] [Google Scholar]
  • 56.Yoon S., Lee Y., Kim J., Lee S., Lee J., Kim J., et al. Enhanced lycopene production in Escherichia coli engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonate. Biotech. Bioeng. 2006;94:1025–1032. doi: 10.1002/bit.20912. [DOI] [PubMed] [Google Scholar]
  • 57.Johnston J.M., Bulloch E.M. Advances in menaquinone biosynthesis: sublocalisation and allosteric regulation. Curr. Opin. Struct. Biol. 2020;65:33–41. doi: 10.1016/j.sbi.2020.05.005. [DOI] [PubMed] [Google Scholar]
  • 58.Zhou M., Wu J., Hu L., Hu W., Huang J., Huang X., et al. Enhanced vitamin K2 production by engineered Bacillus subtilis during leakage fermentation. World J. Microbiol. Biotechnol. 2023;39:224. doi: 10.1007/s11274-023-03671-8. [DOI] [PubMed] [Google Scholar]
  • 59.Yi Y., Jin X., Chen M., Coldea T.E., Yang H., Zhao H. Brij-58 supplementation enhances menaquinone-7 biosynthesis and secretion in Bacillus natto. Appl. Microbiol. Biotechnol. 2023;107:5051–5062. doi: 10.1007/s00253-023-12640-y. [DOI] [PubMed] [Google Scholar]
  • 60.Özkan M., Yılmaz H., Ergenekon P., Erdoğan E.M., Erbakan M. Microbial membrane transport proteins and their biotechnological applications. World J. Microbiol. Biotechnol. 2024;40:71. doi: 10.1007/s11274-024-03891-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Saier M.H., Reddy V.S., Moreno-Hagelsieb G., Hendargo K.J., Zhang Y., Iddamsetty V., et al. The transporter classification database (TCDB): 2021 update. Nucleic Acids Res. 2021;49:D461–D467. doi: 10.1093/nar/gkaa1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Saier M.H., Reddy V.S., Tsu B.V., Ahmed M.S., Li C., Moreno-Hagelsieb G. The transporter classification database (TCDB): recent advances. Nucleic Acids Res. 2016;44:D372–D379. doi: 10.1093/nar/gkv1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Saier M.H., Reddy V.S., Tamang D.G., Västermark A. The transporter classification database. Nucleic Acids Res. 2014;42:D251–D258. doi: 10.1093/nar/gkt1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Sathesh-Prabu C., Shin K.S., Kwak G.H., Jung S.-K., Lee S.K. Microbial production of fatty acid via metabolic engineering and synthetic biology. Biotechnol. Bioproc. Eng. 2019;24:23–40. [Google Scholar]
  • 65.Rm L., Mg P., Ma K., Bf P. Identification of transport proteins involved in free fatty acid efflux in Escherichia coli. J. Bacteriol. 2013;195:135–144. doi: 10.1128/JB.01477-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Wu J., Wang Z., Zhang X., Zhou P., Xia X., Dong M. Improving medium chain fatty acid production in Escherichia coli by multiple transporter engineering. Food Chem. 2019;272:628–634. doi: 10.1016/j.foodchem.2018.08.102. [DOI] [PubMed] [Google Scholar]
  • 67.Chen B., Ling H., Chang M.W. Transporter engineering for improved tolerance against alkane biofuels in Saccharomyces cerevisiae. Biotechnol. Biofuels. 2013;6:21. doi: 10.1186/1754-6834-6-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Geng Z., Ge J., Cui W., Zhou H., Deng J., Xu B. Efficient De Novo biosynthesis of heme by membrane engineering in Escherichia coli. Int. J. Mol. Sci. 2022;23:15524. doi: 10.3390/ijms232415524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Wang L., Li N., Yu S., Zhou J. Enhancing caffeic acid production in Escherichia coli by engineering the biosynthesis pathway and transporter. Bioresour. Technol. 2023;368:128320. doi: 10.1016/j.biortech.2022.128320. [DOI] [PubMed] [Google Scholar]
  • 70.Bishop D.G., Work E. An extracellular glycolipid produced by Escherichia coli grown under lysine-limiting conditions. Biochem. J. 1965;96:567–576. doi: 10.1042/bj0960567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Deatherage B.L., Cookson B.T. Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life. Infect. Immun. 2012;80:1948–1957. doi: 10.1128/IAI.06014-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Toyofuku M., Schild S., Kaparakis-Liaskos M., Eberl L. Composition and functions of bacterial membrane vesicles. Nat. Rev. Microbiol. 2023;21:415–430. doi: 10.1038/s41579-023-00875-5. [DOI] [PubMed] [Google Scholar]
  • 73.Sartorio M.G., Pardue E.J., Feldman M.F., Haurat M.F. Bacterial outer membrane vesicles: from discovery to applications. Annu. Rev. Microbiol. 2021;75:609–630. doi: 10.1146/annurev-micro-052821-031444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Fordjour E., Bai Z., Li S., Li S., Sackey I., Yang Y., et al. Improved membrane permeability via Hypervesiculation for in situ Recovery of lycopene in Escherichia coli. ACS Synth. Biol. 2023;12:2725–2739. doi: 10.1021/acssynbio.3c00306. [DOI] [PubMed] [Google Scholar]
  • 75.Reifenrath M., Oreb M., Boles E., Tripp J. Artificial ER-derived vesicles as synthetic organelles for in Vivo compartmentalization of Biochemical pathways. ACS Synth. Biol. 2020;9:2909–2916. doi: 10.1021/acssynbio.0c00241. [DOI] [PubMed] [Google Scholar]
  • 76.Lee E., Choi D., Kim D., Kim J., Park J.O., Kim S., et al. Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus -derived membrane vesicles. Proteomics. 2009;9:5425–5436. doi: 10.1002/pmic.200900338. [DOI] [PubMed] [Google Scholar]
  • 77.Brown L., Wolf J.M., Prados-Rosales R., Casadevall A. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat. Rev. Microbiol. 2015;13:620–630. doi: 10.1038/nrmicro3480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Briaud P., Carroll R.K. Extracellular vesicle Biogenesis and functions in Gram-positive bacteria. Infect Immun. 2020;88:e00433–e00520. doi: 10.1128/IAI.00433-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Pandey A., Shin K., Patterson R.E., Liu X.-Q., Rainey J.K. Current strategies for protein production and purification enabling membrane protein structural biology. Biochem. Cell Biol. 2016;94:507–527. doi: 10.1139/bcb-2015-0143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Jumper J., Evans R., Pritzel A., Green T., Figurnov M., Ronneberger O., et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583–589. doi: 10.1038/s41586-021-03819-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Abramson J., Adler J., Dunger J., Evans R., Green T., Pritzel A., et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493–500. doi: 10.1038/s41586-024-07487-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Liao X., Ma H., Tang Y.J. Artificial intelligence: a solution to involution of design–build–test–learn cycle. Curr. Opin. Biotechnol. 2022;75:102712. doi: 10.1016/j.copbio.2022.102712. [DOI] [PubMed] [Google Scholar]
  • 83.Ramzi A.B., Baharum S.N., Bunawan H., Scrutton N.S. Streamlining natural products Biomanufacturing with Omics and machine learning driven microbial engineering. Front. Bioeng. Biotechnol. 2020;8:608918. doi: 10.3389/fbioe.2020.608918. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data are contained within the manuscript. All reagents are available upon request from the authors.


Articles from Journal of Lipid Research are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES